SCHEMBL225264

SCHEMBL225264

Nc1ccc2c(c1)Cc1cc(N=Cc3ccc4c(c3)Cc3ccccc3-4)ccc1-2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.62
ALDH1A1 P00352 3/20 0.62
LMNA P02545 2/20 0.62
RAB9A P51151 2/20 0.62
HPGD P15428 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
KDM4E B2RXH2 2/20 0.62
NPC1 O15118 1/20 0.62
CYP1A2 P05177 6/20 0.59
CYP3A4 P08684 3/20 0.59
CYP2C19 P33261 2/20 0.59
CYP2C9 P11712 1/20 0.59
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TLR9 Q9NR96 1/20 0.38
HTR2C P28335 2/20 0.37
HTR2B P41595 2/20 0.37
DRD2 P14416 1/20 0.37
ADRA1D P25100 1/20 0.37
HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL225263 1.00 MAPT (0.62) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL226568 0.92 CYP1A2 (0.68) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL225068 0.92 CYP1A2 (0.68) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL225067 0.92 CYP1A2 (0.68) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL226567 0.92 CYP1A2 (0.68) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL12416593 0.83 CYP1A2 (0.69) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL23989284 0.79 RAB9A (1.00) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL225901 0.79 RAB9A (1.00) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL29556700 0.79 RAB9A (1.00) MAPTALDH1A1LMNARAB9AHPGD
SCHEMBL2454306 0.78 ALDH1A1 (0.61) MAPTALDH1A1LMNARAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004386-A1 CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME UNIVERSITE DE MONTREAL (CA) 2012-01-05 US disclosed
US-8034895-B2 Conjugated thiophenes having conducting properties and synthesis of same Université de Montréal (CA) 2011-10-11 US disclosed
US-20070287842-A1 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same UNIVERSITE DE MONTREAL (CA) 2007-12-13 US disclosed
WO-2005073265-A1 CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME UNIVERSITE DE MONTREAL (CA) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287842-A1 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same DDT, DDC, TRPA1 MAPT 233/4885ALDH1A1 91/4885LMNA 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.